GT200700075A - Derivados de eter diarilico y usos de los mismos - Google Patents
Derivados de eter diarilico y usos de los mismosInfo
- Publication number
- GT200700075A GT200700075A GT200700075A GT200700075A GT200700075A GT 200700075 A GT200700075 A GT 200700075A GT 200700075 A GT200700075 A GT 200700075A GT 200700075 A GT200700075 A GT 200700075A GT 200700075 A GT200700075 A GT 200700075A
- Authority
- GT
- Guatemala
- Prior art keywords
- diarilico
- eter
- derivatives
- same
- antagon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
ESTA INVENCIÓN PRESENTA COMPUESTOS DE FÓRMULA GENERAL (I) QUE ACTÚAN COMO ANTAGONISTAS EN LOS RECEPTORES OPIOIDES MU, KAPPA Y/O DELTA Y POR TANTO SON ÚTILES EN EL TRATAMIENTO DE ENFERMEDADES, AFECCIONES Y/O TRASTORNOS QUE SE BENEFICIAN DE TAL ANTAGONISMO EN ANIMALES, EN LA QUE R1, R2, R3, R4, R5 Y R6 TAL Y COMO SE DESCRIBEN EN EL EXPEDIENTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82494406P | 2006-09-08 | 2006-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200700075A true GT200700075A (es) | 2008-09-19 |
Family
ID=38963180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200700075A GT200700075A (es) | 2006-09-08 | 2007-09-07 | Derivados de eter diarilico y usos de los mismos |
Country Status (17)
Country | Link |
---|---|
US (1) | US7618996B2 (es) |
EP (1) | EP2064199A1 (es) |
JP (1) | JP2010502688A (es) |
KR (1) | KR20090051778A (es) |
CN (1) | CN101511808A (es) |
AR (1) | AR062679A1 (es) |
AU (1) | AU2007297285A1 (es) |
CA (1) | CA2662766C (es) |
CL (1) | CL2007002611A1 (es) |
GT (1) | GT200700075A (es) |
IL (1) | IL197154A0 (es) |
MX (1) | MX2009002527A (es) |
NO (1) | NO20091052L (es) |
PE (1) | PE20080834A1 (es) |
TW (1) | TW200831074A (es) |
UY (1) | UY30577A1 (es) |
WO (1) | WO2008032156A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008142454A1 (en) | 2007-05-22 | 2008-11-27 | Prosidion Limited | Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8063247B2 (en) | 2007-09-07 | 2011-11-22 | Prosidion Limited | Bicyclic aryl and heteroaryl receptor modulators |
US7709522B2 (en) | 2008-01-22 | 2010-05-04 | Eli Lilly And Company | Kappa selective opioid receptor antagonist |
US8846655B2 (en) | 2009-10-30 | 2014-09-30 | Janssen Pharmaceutica, Nv | 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
TW201343629A (zh) * | 2012-01-31 | 2013-11-01 | Lilly Co Eli | 可作為mogat-2抑制劑之新穎芐磺醯胺衍生物 |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
CN111925325B (zh) * | 2020-02-17 | 2021-12-17 | 浙江大学 | 一种二芳香醚类化合物的合成方法 |
US20220370409A1 (en) | 2021-05-04 | 2022-11-24 | Janssen Pharmaceuticals, Inc. | Compositions And Methods For The Treatment Of Depression |
US11998524B2 (en) | 2022-03-07 | 2024-06-04 | Janssen Pharmaceuticals, Inc. | Forms of aticaprant |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0827746B1 (en) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
SK632003A3 (en) | 2000-07-13 | 2003-06-03 | Lilly Co Eli | Beta3 adrenergic agonists |
US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
ATE308522T1 (de) | 2002-05-30 | 2005-11-15 | Lilly Co Eli | Opioidrezeptorantagonisten |
RU2005111225A (ru) * | 2002-09-18 | 2005-08-27 | Оно Фармасьютикал Ко., Лтд. (Jp) | Производные триазаспиро[5.5]ундекана и лекарственные средства, содержащие их в качестве активного ингредиента |
CA2499690C (en) * | 2002-09-19 | 2011-05-24 | Eli Lilly And Company | Diaryl ethers as opioid receptor antagonist |
DE602004016127D1 (de) | 2003-03-07 | 2008-10-09 | Lilly Co Eli | Antagonisten der opioidrezeptoren |
EP1613597B1 (en) | 2003-03-07 | 2007-11-07 | Eli Lilly and Company | 6-substituted nicotinamide derivatives as opioid receptor antagonists |
CA2549009A1 (en) | 2003-12-12 | 2005-07-07 | Eli Lilly And Company | Opioid receptor antagonists |
US7414132B2 (en) | 2003-12-22 | 2008-08-19 | Eli Lilly And Company | Opioid receptor antagonists |
ATE399164T1 (de) | 2004-03-12 | 2008-07-15 | Lilly Co Eli | Antagonisten des opioidrezeptors |
CA2558568A1 (en) | 2004-03-12 | 2005-09-29 | Eli Lilly And Company | Opioid receptor antagonists |
ES2379362T3 (es) | 2004-03-15 | 2012-04-25 | Eli Lilly And Company | Antagonistas del receptor opioide |
US7939528B2 (en) | 2005-10-13 | 2011-05-10 | Glaxosmithkline Llc | Heterocycle compounds |
-
2007
- 2007-08-27 WO PCT/IB2007/002523 patent/WO2008032156A1/en active Application Filing
- 2007-08-27 MX MX2009002527A patent/MX2009002527A/es unknown
- 2007-08-27 CN CNA2007800330762A patent/CN101511808A/zh active Pending
- 2007-08-27 CA CA2662766A patent/CA2662766C/en not_active Expired - Fee Related
- 2007-08-27 KR KR1020097007119A patent/KR20090051778A/ko not_active Application Discontinuation
- 2007-08-27 AU AU2007297285A patent/AU2007297285A1/en not_active Abandoned
- 2007-08-27 EP EP07804870A patent/EP2064199A1/en not_active Withdrawn
- 2007-08-27 JP JP2009527215A patent/JP2010502688A/ja active Pending
- 2007-09-06 AR ARP070103936A patent/AR062679A1/es not_active Application Discontinuation
- 2007-09-06 PE PE2007001196A patent/PE20080834A1/es not_active Application Discontinuation
- 2007-09-06 UY UY30577A patent/UY30577A1/es not_active Application Discontinuation
- 2007-09-07 GT GT200700075A patent/GT200700075A/es unknown
- 2007-09-07 CL CL200702611A patent/CL2007002611A1/es unknown
- 2007-09-07 TW TW096133608A patent/TW200831074A/zh unknown
- 2007-09-10 US US11/852,358 patent/US7618996B2/en not_active Expired - Fee Related
-
2009
- 2009-02-19 IL IL197154A patent/IL197154A0/en unknown
- 2009-03-09 NO NO20091052A patent/NO20091052L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2007002611A1 (es) | 2008-03-14 |
US7618996B2 (en) | 2009-11-17 |
CA2662766A1 (en) | 2008-03-20 |
NO20091052L (no) | 2009-04-06 |
WO2008032156A1 (en) | 2008-03-20 |
US20080070887A1 (en) | 2008-03-20 |
JP2010502688A (ja) | 2010-01-28 |
MX2009002527A (es) | 2009-03-20 |
AU2007297285A1 (en) | 2008-03-20 |
CA2662766C (en) | 2011-08-09 |
AR062679A1 (es) | 2008-11-26 |
PE20080834A1 (es) | 2008-07-19 |
UY30577A1 (es) | 2008-05-02 |
KR20090051778A (ko) | 2009-05-22 |
TW200831074A (en) | 2008-08-01 |
IL197154A0 (en) | 2009-11-18 |
EP2064199A1 (en) | 2009-06-03 |
CN101511808A (zh) | 2009-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200700075A (es) | Derivados de eter diarilico y usos de los mismos | |
SV2007002007A (es) | Compuestos de quinolina sustituidos ref. pc 25932a | |
EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
GT200800187A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
GT200700024A (es) | Derivados de amina | |
CL2008000946A1 (es) | Compuestos derivados de pirrolopirimidina, inhibidores de cianasa jak3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de rechazo de transplantes, enfermedades autoinmun | |
ECSP077223A (es) | Indazoles utiles en el tratamiento de enfermedades cardiovasculares | |
ECSP13012967A (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
CR10309A (es) | "compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1" | |
ME01532B (me) | Jedinjenja | |
UY32391A (es) | Compuestos amino-heterocíclicos | |
ECSP11010885A (es) | Heteroarilos sustituidos | |
NI201100084A (es) | Antagonistas del receptor de orexina de isonicotinamida. | |
SV2009003276A (es) | Antagonistas de receptor de orexina de diazepan sustituido | |
UY31314A1 (es) | Amidas heterociclicas y sus métodos de uso-976 | |
SV2009003411A (es) | Compuestos de amino-heterociclico | |
PA8675701A1 (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilización | |
GT200600197A (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
SV2009003307A (es) | Quinazolinas para la inhibicion de pdk1 | |
PA8667201A1 (es) | Nuevos compuestos farmaceuticos | |
GT200700096A (es) | Compuestos de pirazolina | |
GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
CY1111977T1 (el) | Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
SV2009003212A (es) | Inhibidores de metaloproteasa derivados de heterociclicos ref. prd2727svpct |